A comparison of treosulfan and carboplatin in patients with ovarian cancer not suitable for treatment with cisplati
Completed
- Conditions
- Ovarian cancerCancerOvarian
- Registration Number
- ISRCTN88345833
- Lead Sponsor
- Cancer Research UK (CRUK) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Not considered for cisplatin =75 mg/m2
2. Stages Ic-IV
3. Histologically proven epithelial ovarian cancer
4. Life expectancy .3 months
5. World Health Organisation (WHO) Performance status 0-3
6. Creatinine clearance =20 ml/min White Blood Cell (WBC) Count =3.5 x 10^9/l Platelets =100 x 10^9/l
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration